These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12566163)

  • 1. Up-regulation of mu-opioid receptor-mediated G-protein activation in protein kinase Cgamma knockout mice following repeated naloxone treatment.
    Narita M; Suzuki M; Mizoguchi H; Narita M; Yajima Y; Sakurada S; Tseng LF; Suzuki T
    Neurosci Lett; 2003 Feb; 338(2):103-6. PubMed ID: 12566163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
    Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
    J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment.
    Narita M; Mizoguchi H; Nagase H; Suzuki T; Tseng LF
    Brain Res; 2001 Sep; 913(2):170-3. PubMed ID: 11549382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a deletion of protein kinase C gamma isoform in the G-protein activation mediated through opioid receptor-like-1 and mu-opioid receptors in the mouse pons/medulla.
    Narita M; Mizoguchi H; Khotib J; Suzuki M; Ozaki S; Yajima Y; Narita M; Tseng LF; Suzuki T
    Neurosci Lett; 2002 Oct; 331(1):5-8. PubMed ID: 12359310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein activation by endomorphins in the mouse periaqueductal gray matter.
    Narita M; Mizoguchi H; Narita M; Dun NJ; Hwang BH; Endoh T; Suzuki T; Nagase H; Suzuki T; Tseng LF
    J Biomed Sci; 2000; 7(3):221-5. PubMed ID: 10810240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions.
    Maher CE; Selley DE; Childers SR
    Biochem Pharmacol; 2000 Jun; 59(11):1395-401. PubMed ID: 10751548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
    Madia PA; Navani DM; Yoburn BC
    Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
    Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
    Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
    Cinar R; Szücs M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC; Purohit V; Patel K; Zhang Q
    Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a mu-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice.
    Ohsawa M; Mizoguchi H; Narita M; Kamei J; Nagase H; Tseng LF
    Eur J Pharmacol; 2000 Jul; 401(1):55-8. PubMed ID: 10915837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
    Kramer HK; Simon EJ
    J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced mu-opioid responses in the spinal cord of mice lacking protein kinase Cgamma isoform.
    Narita M; Mizoguchi H; Suzuki T; Narita M; Dun NJ; Imai S; Yajima Y; Nagase H; Suzuki T; Tseng LF
    J Biol Chem; 2001 May; 276(18):15409-14. PubMed ID: 11278552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat.
    Narita M; Miyoshi K; Narita M; Suzuki T
    Neuroscience; 2007 Feb; 144(3):777-82. PubMed ID: 17156932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.